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ABSTRACT We have evaluated the role of major histo-
compatibility complex-encoded class II (Ia) molecules as trans-
membrane signaling receptors in the T helper cell-dependent
activation of B lymphocytes. For these studies, we utilized the
murine B-cell lymphoma CH12, which expresses both I-A and
I-E class II molecules. In addition, CH12 cells carry IgM of
known antigen specificity and require both specific antigen
and Ia-restricted T-cell help for the induction of antibody se-
cretion. In this respect, they resemble normal resting B cells.
We have studied the ability of antigen-specific or alloreactive
T helper cells reactive with either the I-A or the I-E molecules
on CH12 to be activated and their ability to stimulate antibody
production by CH12. The results show that, although CH12
cells present antigen to T helper cells that interact with either
the I-A or the I-E molecules, CH12 cells are stimulated to se-
crete antibody only by T helper cells reactive with their I-E
molecules. Our data demonstrate that class II molecules are
transducers of signals for B-cell excitation in addition to serv-
ing a restricting function for helper T-cell stimulation. More-
over, the data demonstrate that these two functions, T-cell
stimulation and B-cell excitation, are discrete and need not be
expressed by the same Ia molecule.
Helper T (Th) cells are stimulated after recognition of anti-
gen and class II major histocompatibility complex (MHC)-
encoded molecules expressed on antigen-presenting cells
(APC) (1). Class II (Ia) molecules are, therefore, considered
to be "restricting elements," which are required to mediate
Th cell activation. In addition to macrophages and other spe-
cialized APC, B lymphocytes express Ia molecules and can
present antigen to Th cells (2).
Th cell-dependent activation of normal resting (Go) B lym-
phocytes also involves the interaction of Th cells with anti-
gen and Ia molecules on the B-cell membrane (3-6). After
the binding of antigen by B-cell surface immunoglobulin
(sIg), Th cells interact with antigen and Ia molecules and the
B lymphocytes are shifted from the resting state. Thereafter,
antigen-nonspecific and MHC-unrestricted B-cell stimulat-
ing factors are sufficient to promote the growth and differen-
tiation of these "excited" B cells (7, 8). It is not known
whether the Ia molecules serve only as restricting elements
for Th cell activation during T-B interactions or whether
they also serve as transducers of signals for B-lymphocyte
excitation.
We have investigated the role played by Ia molecules in B-
cell activation, using the CH12 B-cell lymphoma. CH12 cells
have sIg specific for a determinant found on sheep erythro-
cytes (SRBC) and have activation properties similar to rest-
ing B lymphocytes (9). These cells have been used previous-
ly to demonstrate that the sIg molecule on the B-cell mem-
brane is an activation receptor for B-cell excitation (10). In
the current study, we have taken advantage of the fact that
CH12 expresses both I-A-encoded and I-E-encoded class IT
molecules to determine whether Th cells that interact with
these molecules can always stimulate CH12 to antibody se-
cretion. We report here that, although Th cells that interact
with either the I-A or the I-E molecules are themselves acti-
vated, only the interaction with I-E molecules causes CH12
to produce antibody. These results prove not only that Ia-
encoded molecules are signaling receptors for B-cell excita-
tion, but also that the two functions of these molecules, Th
cell stimulation and B cell excitation, are separate.
MATERIALS AND METHODS
Animals. B10.H-2aH-4bp/Wts (2a4b) mice were bred at the
University of North Carolina. The H-2 haplotype of these
mice is kkkd, signifying marker alleles in the K, I-A (A/3, Aa,
Ej3). I-E (Ea), and D regions, respectively. All strains will be
referred to using this four-letter shorthand nomenclature.
Underlining denotes sharing of alleles with those carried by
CH12. B10.A QW), B10.A(3R) or B10.A(5R) (bbkd),
B10.MBR (bkkq), C3H/HeJ (kkkk), and HTI (bbbd) mice
were purchased from The Jackson Laboratory, or bred in the
animal colony at Duke University. B10.A(3R) (bbkd), and
B10.A(4R) (kkbb) mice were kindly provided by Jeffrey Fre-
linger (University of North Carolina). B10.S(8R) (kkss),
B10.S(9R) (sskd), and B10.TBR2 (skbb) mice were provided
by Cella David (Mayo Clinic, Rochester, MN).
Th Cells. Alloreactive Th cell lines were enriched in pri-
mary mixed lymphocyte cultures as described (11). Keyhole
limpet hemocyanin (KLH)-specific Th cell lines were estab-
lished with T cells purified from draining lymph nodes of
immunized mice (12). These T cells were restimulated with
irradiated filler cells and antigen once every two weeks. The
specificity ofeach of the lines used in these studies was inde-
pendently confirmed by restimulation with APC or stimula-
tor cell populations from mice of recombinant haplotypes.
KLH-specific Th cells were cloned by using limiting dilu-
tion. Spleen cells from mice immunized 4-5 days earlier with
SRBC (100 gl of 0.1% suspension) were used as a source of
SRBC-primed Th cells (13).
CH12 B Lymphoma CF14 The induction and characteriza-
tion of the CH12 lymphoma have been described (14). The
sIg molecule of CH12 cells is an IgM (QL, K) with specificity
for SRBC. CH12 cells express both the I-Ak and I-Ek class II
molecules (9, 14). These cells display activation require-
ments similar to those of normal resting B cells; specific anti-
gen and H-2-restricted interactions with Th cells are required
Abbreviations: Th, helper T (lymphocyte); MHC, major histocom-
patibility complex; APC, antigen-presenting cells; slg, surface
immunoglobulin; SRBC, sheep erythrocytes; KLH, keyhole limpet
hemocyanin; pfc, plaque-forming cell(s); IL-2, interleukin 2 (T-cell
growth factor).
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to induce their differentiation into antibody-secreting cells
(9, 10). CH12 cells can also be stimulated with lipopolysac-
charide (LPS) (9). CH12 is maintained as ascites in 2a4b or
B1O.A mice. In some experiments, a clone of CH12
(CH12.6) propagated in vitro was used; cloning was achieved
by limiting dilution.
Helper Assays and Enumeration of Antibody-Secreting
Cells. Cells were cultured exactly as described previously (9,
10). Cultures contained 1 CH12 cells per ml and various
numbers of alloreactive or antigen- (KLH or SRBC) specific
Th cells. In the case of KLH-specific Th cells, KLH was
added at various concentrations; SRBC were added at
106/ml. Th cells were yirradiated [1500 rads (1 rad = 0.01
gray)] before use in all experiments. After 3 or 4 days of
culture, CH12 cells were counted and plaqved on SRBC
monolayers, using the method of Cunningham and Szenburg
(15). Results are expressed as plaque-forming cells (pfc) per
ml or as pfc per 10 viable recovered CH12 cells on the day
of assay; in some experiments the number of pfc are present-
ed as the percent of recovered CH12 cells.
Measurement of T-Cell Activation. T-cell activation was
assayed by measuring the release of the T-cell-derived lym-
phokine, interleukin 2 (IL-2) (12) or T-cell proliferation. T-
cell proliferation was measured by [3H]thymidine uptake
(11, 12). When normal spleen cells were usea as APC, they
were irradiated (1500 rads) as described (12). CH12 cells
were treated with mitomycin C (50 pg/ml) prior to use as
APC (11).
RESULTS
CH12 cells can be stimulated to antibody secretion by using
H-2-compatible SRBC-ppmed splenic T cells and SRBC as
specific antigen. Th cells not restricted to MHC-encoded de-
terminants expressed by CH12 did not stimulate the lympho-
ma, even when APC matching the T-cell haplotype were in-
cluded in culture, demonstrating that a direct interaction be-
tween Th cells and CH12 is required for activation (9). As
reported previously (9) and as shown in Table 1, however,
not all SRBC-specific Th cells restricted for determinants
expressed on CH12 are able to induce differentiation. Th
cells from BlO.A(4R) mice (kkbb) do not stimulate anti-
SRBC pfc from CH12. These same BlO.A(4R) T cells do
stimulate SRBC-specific responses in normal unprimed B
cells from H-2a mice, demonstrating that they include com-
petent Th cells. Previous work has demonstrated that SRBC-
primed Th cells from BlO.A(3R) mice (bbkd) are capable of
stimulating an antibody response in CH12 cells (9). Since Th
cell interactions occur with Ia-encoded molecules on B cells,
these data imply that there is a difference in the function of
the I-A and I-E molecules on CH12 cells.
To evaluate this difference, alloreactive Th cell lines spe-
cific for the I-A, I-E, or both molecules on the CH12 mem-
brane were tested for their ability to induce the differentia-
tion of CH12. As shown in Fig. 1, alloreactive T cells specif-
Table 1. SRBC-primed splenic T cells from B1O.A(4R) mice do
not stimulate CH12
2a4b spleen
Source of H-2 CH12 B B cells,
T cells K A E D cells, % pfc* pfc/culture
None 0.5 ± 0.2 0
2a4b k k k d 2.2 0.3 272
B1O.A(4R) k k b b 0.6 ± 0.3 176
SRBC (106/ml) were included in all cultures. CH12 were cultured
at 105/ml; T-cell-depleted 2a4b spleen cells were cultured at 10'/ml.
SRBC-primed T cells were irradiated (1500 rads) prior to use. pfc
were enumerated on day 3 (CH12) or day 4 (normal spleen cells).
*pfc are expressed as percent of viable recovered CH12 secreting
antibody on day 3.
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FIG. 1. Alloreactive Th cell-induced differentiation of CH12.
CH12 cells were cultured with increasing numbers of alloreactive
HTI anti-B1O.MBR (bbbd anti-bkq), B1O.A(5R) anti-B1O.MBR
(bbkd anti-bkkq), or HTI anti-B1O.A(5R) (bbbd anti-bbkd) in the
presence (e) or absence (o) of SRBC. T cells were irradiated (1500
rads) prior to use. The pfc measured on day 3 of culture are ex-
pressed as pfc per culture (Top) or pfc per 106 recovered CH12 cells
(Middle). In Bottom, the proliferative responses of the Th cells are
shown with CH12 cells (A) or normal B10.A spleen cells (A) as APC.
[3H]Thymidine incorporation into proliferating T cells was mea-
sured on day 3 of culture. Vertical bars represent standard devi-
ations of replicate cultures.
ic for I-A plus I-E or for I-E alone were able to activate
CH12. In contrast, I-A-specific Th cells did not induce dif-
ferentiation at any multiplicity tested. Nevertheless, these I-
A-specific Th cells were themselves activated to proliferate
to a degree equal to that observed when stimulated with nor-
mal allogeneic spleen cells (Fig. 1). This indicates that the
failure of these Th cells to stimulate CH12 was not due to
their own inactivity.
We next analyzed the MHC-restricted activation of CH12,
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FIG. 2. Activation of CH12 using KLH-specific Th cell lines.
KLH-specific Th cells were derived from B1O.A (a), B10.A(4R) (b),
or B1O.A(3R) (c) mice, and increasing numbers were tested for their
ability to stimulate CH12 cells in the presence (-) or absence (o) of
KLH at 100 pg/ml. All cultures contained 106 SRBC. a also shows
the response of CH12 to Escherichia coli lipopolysaccharide (Difco
055:B5) at 100 /g/ml (A). Vertical bars represent SD of quadrupli-
cate cultures.
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FIG. 3. Activation of KLH-specific B1O.A(3R) and B1O.A(4R) T
cells with CH12 as APC. T cells (3 x 104) were cultured in 200-,I
volumes for 3 days with APC and various amounts of KLH.
[3H]Thymidine incorporated during the last 6 hr of culture was mea-
sured. As APC, 6 x 105 B1O.A spleen cells (o), 10' CH12.6 cells (o),
or 6 x 105 B1O.A(3R) spleen cells (o) were used. Prior to labeling
with [3H]thymidine, 50 ul of supernatants from cultures containing
B1O.A(4R) T cells was removed and tested for the ability to support
the growth of IL-2-dependent T cells as described (12). A standard
source of IL-2 (2% EL4 cell supernatant) is shown as a positive con-
trol (*).
BlO.A(4R), and BlO.A(3R) mice, in the presence of KLH
and SRBC. As shown in Fig. 2, KLH-specific Th cells of
B1O.A and BlO.A(3R) origins activated the CH12 cells, while
those from BlO.A(4R) mice did not. Again, the failure to in-
duce CH12 was not due to the lack of activation of the KLH-
specific BlO.A(4R) T cells (Fig. 3). When CH12 cells were
used as APC, the proliferative response of these Th cells and
their IL-2 production were similar to the values obtained
when conventional sources ofAPC were substituted (Fig. 3).
In this experiment, an in vitro propagated cloned line of
CH12 cells (CH12.6) was used as a source ofAPC. Since this
clone, unlike the in vivo CH12 line, is devoid of contaminat-
ing macrophages, these results demonstrate that CH12 cells
alone are functional as APC in the activation of BlO.A(4R) T
cells.
The proliferative response of KLH-specific BlO.A(3R) T
cells, with various sources of APC, is presented in Fig. 3.
These T cells proliferated in response to KLH presented by
CH12.6, B1O.A APC, and BlO.A(3R) APC, although the re-
sponse to antigen presented by the homologous, BlO.A(3R),
APC was consistently greater. This was as expected, since
only the a chain of the I-E molecule is common to these
strains and, therefore, not all of the I-E (E;E!)-restricted T
cells in the BlO.A(3R) population recognize the cross-react-
ing I-E (EkEk) determinants on CH12.
In the previous experiments (Figs. 2 and 3), KLH-specific
T cells from uncloned long-term cell lines were used as a
source of T-cell help. Although most of these cells are Lyt-1
positive, and we have never detected Lyt-2-bearing cells
(12), we wished to rule out the possible effects of suppressor
Source of APC [ 3t
H-2
Strain KAED KLH S500 1000
B1O.A kkkd ,
C3H k k k k ;
B1QTBR2 bb :
B1O.S(8R) k k s s +
BlQS(9R) s s k d ;
Table 2. Antigen presentation by CH12 cells to I-Ak-restricted
T-cell clones
[3H]Thymidine uptake, cpm x 10-3
Cell line KLH B10.A CH12.6 CH12
Parent line - 0.6 ± 0.0 0.8 ± 0.2 ND
+ 5.8 0.4 3.3 ± 0.4 ND
Clone E - 0.1 ± 0.1 1.1 ± 0.3 1.2 ± 0.3
+ 22.0 ± 0.5 11.4 ± 2.0 82.7 ± 8.3
Clone F - 0.1 ± 0.0 1.2 ± 0.2 2.5 ± 0.4
+ 4.6 ± 0.6 4.0 ± 0.7 21.8 ± 1.7
T cells (104 per well) from the parent B10.A KLH-specific T cell
line or from each of two I-Ak-restricted T cell clones (E and F)
derived from the parent line were cultured for 3 days with 10 jug of
KLH per culture and the designated APC in 200-1ul volumes. APC
were 5 x 101 per culture B10.A spleen cells (irradiated 1500
rads) or 104 CH12 ascites tumor cells or the in vitro clone CH12.6
(mitomycin C treated). Cultures were pulsed with 0.5 AGCi (1 Ci = 37
GBq) of [3H]thymidine during the final 15 hr of culture. Results are
mean ± SD; ND, not done.
T cells in the KLH-specific lines as an explanation for the
failure of the B1O.A(4R) Th cells to stimulate CH12 to pro-
duce antibody. We isolated I-Ak-restricted Th cell clones
from a KLH-specific B1O.A T cell line and tested two of
these for their ability to trigger responses in CH12. The
specificities of these two clones are presented in Fig. 4. That
these two clones were helper cell clones was confirmed by
their ability to stimulate anti-SRBC pfc responses in a "by-
stander" assay (16) with resting B cells from B1O.A mice (not
shown). Both of these clones proliferated in response to
KLH presented by CH12 cells, whether the in vivo CH12
line or the CH12.6 subclone was used as APC (Table 2). The
higher activity generated with the in vivo CH12 might be due
to contaminating host macrophages (10), but this has not
been evaluated further. In agreement with the results with
the long-term B1O.A(4R) helper lines, neither clone stimulat-
ed CH12 to secrete antibody (Table 3). We conclude that
regulatory effects of other cells that may contaminate the Th
cell lines do not account for the failure of B1O.A(4R) Th cells
to stimulate the CH12 B-cell lymphoma. Rather, this is due
to the inability of CH12 to be triggered by any Th cell popu-
lation that does not interact with the I-E molecule.
DISCUSSION
Ia molecules have been well documented as recognition
structures for T-cell activation, especially Th cells (1). The
data presented in this paper demonstrate a second function,
that of transducers of signals for B-cell excitation. This fol-
lows from the evidence that, while both the I-A and I-E mol-
Hlthymidine incorporation, cpm
10000 C500 1000
FIG. 4. Proliferative responses of I-A-restricted KLH-specific T-cell clones E (A) and F (B) to KLH (100 pg/ml) with different sources of
APC as shown. Clones were derived from a long-term KLH-specific Th cell line from B1O.A mice. Cultures contained 104 T cells and 106 of the
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Table 3. Failure of I-A-restricted helper T cells to activate CH12
Helper T cells* Activation of CH12t
Cells x 10- pfc/106
Source per culture pfc/culture cells
None 5,800 3,021
Parent line 3 29,500 32,065
30 94,200 98,125
Clone E 3 5,800 2,788
30 1,400 909
Clone F 3 600 242
30 500 272
*T cells are those described in Table 2; they were irradiated (1500
rads) prior to use. All cultures contained KLH (50 pg/ml) and
SRBC (1 x 106/ml).
tActivation of CH12 with lipopolysaccharide (100 ,ug/ml) was
112,800 pfc per culture, 86,769 pfc per 106 recovered cells. Anti-
SRBC pfc were measured on day 4.
ecules on the CH12 lymphoma are active in presenting anti-
gen to Th cells, only occupation of one, the I-E molecule, led
to activation of CH12 and subsequent antibody production.
The failure to activate CH12 after recognition of the I-A mol-
ecule by Th cells occurred irrespective ofTh cell specificity.
I-A-restricted Th cell specific for two different exogenous
antigens, SRBC and KLH, as well as alloreactive I-A-specif-
ic Th cells, were ineffective. Therefore, the failure of these T
cells to stimulate CH12 cannot be explained by a conven-
tional Ir gene defect. Since both the I-A and I-E molecules
are functional for Th cell activation, we conclude that the
failure to trigger CH12 cells after the interaction of Th cells
with the I-A molecule demonstrates that activation of CH12
via I-E is a direct result of the receptor function of this mole-
cule. The bifunctional nature of class II molecules suggests
that, while Ia molecules are ligands for the T-cell receptor in
T-lymphocyte activation, T-cell receptors are ligands for the
Ia molecule in B-cell excitation.
Various studies on B-cell activation are consistent with
the proposed transducer function of Ia molecules. Although
occupation of sIg by antigen is normally required for Th cell-
dependent activation of resting B cells (10, 17), the require-
ment for sIg-ligand interactions can be bypassed. Under
these conditions, Ia-specific/Ia-restricted Th cells are neces-
sary and sufficient to lead to B-cell stimulation (6, 10, 16, 18,
19), suggesting an excitation function of Ia molecules. Addi-
tional evidence for the transducer nature of Ia molecules
comes from the work of Palacios et al. (20), who demonstrat-
ed that monoclonal anti-HLA-DR antibodies can stimulate
antibody production from human B cells. We have recently
found that monoclonal anti-I-E, but not anti-I-A, antibodies
will stimulate CH12 to secrete antibody (ref. 19; unpublished
data), indicating that binding of an "inert" ligand (the anti-
body) to the Ia receptor may be sufficient to activate B cells
under certain conditions.
It is possible that the receptor function of Ia molecules is
not restricted to B lymphocytes. Since restricted interac-
tions between Th cells and antigen-presenting macrophages
result in macrophage activation as well as Th cell activation
(21, 22), Ia molecules may have transducer function in these
cells as well. Such a role for Ia molecules has previously
been suggested by Larsson et al. (29), and evidence support-
ing this hypothesis was recently reported (30).
The inability to stimulate CH12 by using I-A-restricted Th
cells raises the intriguing question of whether CH12 is a gen-
eral model for normal B-cell activation. There is no doubt
that some B lymphocytes can be stimulated by I-A-restricted
Th cells, but whether these are distinct from those B cells
triggered by I-E-restricted T cells is unknown. An alterna-
tive view is that the I-A molecule on CH12, while easily rec-
ognizable by monoclonal antibodies (9, 14) and capable of
serving as a restricting element for Th cell activation, is in
some way aberrent. One possibility is that the I-A molecule
has a defective cytoplasmic carboxyl terminus that does not
allow its normal transducer function to be expressed.
Certainly, occupation of Ia and sIg receptors is not always
obligatory for B-lymphocyte stimulation. Various methods
have been shown to result in B-lymphocyte proliferation and
differentiation in vitro, some of which bypass the require-
ment for sIg receptor-ligand interactions (6, 10, 16, 18, 19),
Ia receptor-Th cell interactions (23), or both (5, 7). Indeed,
several recent reports (24-26) have demonstrated that MHC-
unrestricted Th cell-derived helper factors are apparently
able to stimulate resting B cells. We suggest that, rather than
being inconsistent with our data and contradicting the pro-
posed transducer function of Ia molecules, these data reflect
another of the redundant methods that result in B-cell activa-
tion in vitro. Whether these various methods also function in
vivo is not known, but it is possible that the high concentra-
tions of antigen and high multiplicities ofTh cells required to
effect bystander responses in vitro are never realized under
in vivo conditions (27). We suggest a minimal model for
physiologic B-cell activation, in which hapten-carrier conju-
gates bridge Th cells and B cells (28), making possible the
simultaneous occupation of two transducer molecules on B
cell membranes, sIg by antigen (10, 17) and Ia by Th cell
receptors.
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